-
Ibudilast, a Phosphodiesterase Inhibitor, Alleviates Huntington’s Disease Pathology through Neuroinflammation Modulation and Signaling Pathway Regulation in a Rat Model
-
Identification and Screening of Candidate Genes for Paroxysmal Movement Disorders by Next Generation Sequencing Approach for Developing Molecular Diagnostics.
-
Identification of Allosteric GCase Correctors Using Revenir™ for the Treatment of GBA1-Parkinson’s Disease
-
Identification of Brain Atrophy Subtypes in Prodromal and Overt Synucleinopathies: A Multicenter Study
-
Identification of Compound Heterozygous and Novel Deep-Intronic TH Mutations in a Chinese Patient with Dopa-Responsive Dystonia
-
Identification of Fall Risk in Patients with Parkinson’s Disease Through Telemonitoring
-
Identification of Novel Blood Biomarkers among Data-Driven Parkinson’s Disease Clusters in Asian Populations
-
Identification of Pre-Diagnostic Biomarkers for Parkinson’s Disease from Plasma Proteome
-
Identification of underlying Lewy body pathology in primary tauopathies by α-synuclein seed amplification assay
-
Identifying and Managing Spasticity in Neurological Shoulder Dysfunction
-
Identifying Barriers and Facilitators to Accessing Care for Members of the Black Diaspora and Hispanic People Affected by Parkinson Disease: A Qualitative Study
-
Identifying key symptoms associated to parkinsonism other than Parkinson’s Disease: a case series
-
Identifying Subjects with Dopamine Transporter Deficit in a Population-based Recruitment Strategy: Kassel Data of Healthy Brain Ageing
-
Identifying the Most Sensitive Patient-reported Items from the MDS-UPDRS that Predict Initiation of PD Medications in Early Disease
-
Idiopathic Parkinson’s disease and Normal pressure Hydrocephalus – a tale of two sisters
-
If Oral Levodopa is not Possible, Keep Calm and Breathe Deeply
-
IGF2 Induce Neuroprotection in PD Preclinical Models by Modulation of Immune Response.
-
ilex Paraguariensis (Yerba mate) modulates the AMPK pathway and downstream key metabolic mechanism that may explain its neuroprotective role.
-
Image-guided Programming versus Conventional Programming in Deep Brain Stimulation: Comparative Study of a Parkinson’s Disease Cohort and Subthalamic Neurostimulation
-
Imaging the Nigrostriatal Pathway in Patients with Idiopathic Normal Pressure Hydrocephalus and Parkinsonism
-
Imaging-based Troubleshooting Deep Brain Stimulation in Parkinson’s Disease
-
Immune cell traits and Parkinson’s disease: A Mendelian randomization study
-
Immunomodulatory Effects Of Covid-19 Vaccination On Inflammatory And Neurotrophic Factors In Parkinson’s Disease: Insights From Clinical Subtypes
-
Immunoproteasome subunits as emerging contributors to neurodegeneration in Parkinson’s Disease
-
Impact of 24-hour Subcutaneous Levodopa/Carbidopa Infusion (ND0612) on Motor State Transitions Throughout the Day
-
Impact of Altered Cerebrovascular Reactivity on Midbrain Degeneration, Perfusion and White Matter
-
Impact of Cognitive Impairment on Mobility and Linguistic Metrics During a Dual-task in PD
-
Impact of Community Boxing Program on Non-motor Symptoms in Individuals with Parkinson’s Disease
-
Impact of DBS STN on motor symptoms, postural instability, QoL in PD patients from the Belarusian population
-
Impact of IPX203 on Parkinson’s patients’ motor states upon awakening: analysis of patient diary data
-
Impact of Patient Input on the Study Execution of a Prospective, Epidemiological Study
-
Impact of Prior Head Trauma on Parkinson’s Disease Experience
-
Impact of Striatal Degeneration on Clinical Phenotype in Idiopathic Normal Pressure Hydrocephalus: A Comparative Analysis
-
Impact of Striatal Degeneration on Patient Reported Symptoms in Idiopathic Normal Pressure Hydrocephalus
-
Impact of sub-acute MPTP exposure on the cerebellum in adult male Balb/c mice
-
Impact of Surrounding Audio-Visual Complexity on Symptomatology of Laryngeal Dystonia: A Virtual Reality Study
-
Impact of Temperature Variation on Emergency Department Visits for Parkinson’s Disease Patients Amongst Two Sites
-
Impact on quality of life and nonmotor symptoms of unilateral magnetic resonance-guided focused ultrasounds (FUS) thalamotomy in patients with essential tremor.
-
Impairment of REM Sleep Architecture: A Potential Biomarker for Parkinson’s Progression
-
Implementation of the Parkinson’s Disease-Health Index (PD-HI), a Novel, Validated, Disease-Specific Patient-Reported Outcome Measure, in a 24-Month Natural History Study
-
Implications of BSCL2 Mutation in the Pathogenesis of Parkinson’s Disease
-
Improved Quantification of DAT-SPECT significantly increases its Performance as an Imaging Biomarker in Parkinson’s Disease
-
Improvement in Uninterrupted Good ON Time and Reduction in OFF Periods with CSAI Treatment
-
Improvement in upper limb spasticity patterns in the elderly following treatment with incobotulinumtoxinA: a pooled analysis
-
Improvement in Upright Stability subscale of mFARS with Vatiquinone Treatment in MOVE-FA: a Phase 3, Double-blind, Placebo-controlled Trial
-
Improving awareness of motor fluctuations in Parkinson’s Disease: an educational patient support program using a waist-worn device.
-
Improving Neuropsychiatric Comorbidity in Geriatric Spinocerebellar Ataxia
-
Improving Work Up amongst Patients with Rare Movement Disorders according to Diagnostic Yield Findings– Update from Single Center Neurogenetic Clinic
-
In Silico Electrophysiology and System Pharmacology Reveal Coupling Between Dopamine Receptors and Ca2+ Channels in Subthalamic Neuronal Cells towards Parkinson’s Disease
-
Incidence and Prevalence of Parkinson’s Disease Among United States Medicare Beneficiaries by Age, Sex, Race/Ethnicity, and Neighborhood Socioeconomic Status 2014-2021
-
Incidence of Depression in the Caregivers of Parkinson’s Disease Patients
-
Incident & Prevalent Dementia in Individuals with Parkinson’s Disease in the Framingham Heart Study
-
Inclusion of PSP-Parkinsonism (PSP-P) phenotype in clinical trials – power calculation
-
Incobotulinumtoxin A to Treat Sialorrhea in Parkinson’s Disease: a Real-life Study: 5-year Interim Results
-
Incorporating the Voice of the Patient and Caregiver into a Multiple System Atrophy (MSA) clinical trial
-
Increased alpha-internexin levels are associated with a higher risk of Parkinson’s disease
-
Increased Brain Free Water is Associated with Regional Gene Expression in Parkinson’s Disease
-
Increased Brain-Age Gap Estimate (BrainAGE) in Neurological Wilson Disease
-
Increased cerebellar grey matter in writer’s cramp patients: a morphometric signature of symptom compensation
-
Increased cholinergic activity in specific brain regions associated with the presence of dyskinesias in Parkinson’s disease: A [18F]-FEOBV PET study
-
Increased Resting Anterior Hippocampus Metabolism and Hippocampus Subfields Structural Abnormalities in Functional Tremor Patients: FDG- PET Study and Volumetric MRI Study
-
Increased Risk of Suicidal Ideation in Patients with Spinocerebellar Ataxias
-
Increasing access to Deep Brain Stimulation for an underserved patient population: A retrospective cohort from an urban hospital in a diverse county in the USA.
-
Increasing diagnostic accuracy of Multiple System Atrophy – A Videolibrary on clinical and imaging features
-
Indentifying Key Features for Predicting Clinical Status in Huntington’s Disease Patients Using Raw Speech Samples: a Lightweight Machine Learning Approach
-
Indications of advanced therapies in Parkinson’s Disease: a retrospective study in a Belgian reference center
-
Inflammation Biomarkers and Free Water Fraction in the Cholinergic Forebrain System in Idiopathic Parkinson’s Disease
-
Influence of Fatigue in Parkinson’s Disease on Variability of Gait Measures
-
Influence of immigration on Parkinson’s disease: analysis of clinical presentation.
-
Influence of the Level of Education on the Change in Cognitive Function in Parkinson´s Disease. A 5-year Follow-up Study.
-
Initial Results After Launch of Best Practice Advisory for Contraindicated Agents in Parkinson’s Disease and Related disorders
-
Initiating a Hybrid-Modality International Movement Disorders Fellowship: A Collaborative Effort Among Latin American Countries
-
Initiation of AT-HOME PD2, a Remote Observational Study of Parkinson’s Disease Clinical Trial Participants
-
Instrument-supported Gait Analysis Characterizes Gait Domain Changes in Patients with Suspected Normal Pressure Hydrocephalus – a Retrospective Study
-
Insulin-like growth factor 2 and inflammatory response in Parkinson Disease: Potential predictor marker
-
Integrated Clinical Research Intern Program: Impact Upon Recruitment of Participants for Therapeutic Studies Aimed at Parkinson’s Disease (PD) Prevention.
-
Integrated management of persons with Parkinsonism: a new model of patient-centered healthcare at home coordinated by a Case Manager via Telenursing.
-
Integrating Non-Motor Symptoms and Gender Variability in Machine Learning for Early Parkinson’s Disease Detection
-
Integrating Parkinson’s Plus Cohorts into the Global Parkinson’s Genetics Program
-
Intelligent Assessment of Abnormal Movements in Neurological Disorders: An Update
-
Intensive Neurophysiological Rehabilitation System As a New Approach for Treatment of ASD Children
-
Inter- and intra-day variability in β-Glucocerebrosidase activity and pathway biomarkers in healthy volunteers and patients with Parkinson’s disease with a GBA1 mutation
-
Interaction of GCase and ganglioside GM1 in the aggregation of α-Synuclein
-
Interim Analysis of the Feasibility of Mediterranean-Ketogenic Dietary Interventions in Parkinson’s Disease
-
Interim Report of Quality of Life Outcomes After Deep Brain Stimulation for Parkinson’s Disease from a Large Global Real-World Study
-
Interim results of a mixed method research-in-action study to evaluate and improve patient and public involvement within the EJS ACT-PD initiative
-
Intermediate Expansion of MARCHF6 causes FAME3 without Epilepsy
-
International Perspectives of Care Partners for People with Parkinson’s Disease
-
Intraepidermal Nerve Fiber Density at Baseline Associates with One-year Clinical Disease Progression in Multiple System Atrophy
-
Intrafamilial phenotypic variability of DYT-ANO3: Analyzing 14 affected members with a novel variant
-
Intraoperative venous air embolism in the semi-sitting position in functional neurosurgery
-
Intraventricular baclofen and bilateral pallidotomy in a pediatric patient with acquired generalized dystonia and refractory status dystonicus
-
Intrinsic Auricular Muscle Zone Stimulation for Moderate-to-Severe Parkinson’s Disease
-
Investigating an Emerging Anxiety-like Phenotype in a Novel Bilateral Rodent Model of Parkinsonian Alpha-Synuclein Pathology
-
Investigating Cognitive Impairments in early Parkinson’s disease
-
Investigating Copy Number Variations in SNCA and PRKN in a Cohort of Kazakhstani Patients with Parkinson’s Disease and Healthy Controls
-
Investigating Impaired Perceptual Decision Making in Cervical Dystonia: A novel paradigm integrating Behavioural and Neural measures
-
Investigating Interrater Reliability of the Unified Huntington’s Disease Rating Scale Motor Component Between Learner and Experienced Rater
-
Investigating the genetic relationship between vitamin B12 deficiency and Parkinson’s disease
-
Investigating the pathogenesis of GBA1-associated Parkinson’s disease using GBA1 isogenic iPSC lines
-
Investigating the Use of 18F-DOPA PET/CT to Improve Diagnosis and Clinical Management of Parkinson’s Disease in South Australian Movement Disorder Clinics.
-
Investigation of the Beta Oscillations of Local Field Potential in the Subthalamic Nucleus of the Parkinsonian Minipig Model
-
Investigation of the Quantitative Impact of T-type Calcium Channels in Subthalamic Nucleus Neurons on Parkinson’s Disease
-
Ionic Plasticity of Midbrain GABAergic Synapses in PD Models
-
iPLA2β controls ER-mitochondria tethering and Ca2+ transfer in Parkinson’s disease
-
iPSC-Based Modeling of SCA12 for Targeted Therapeutic Screening
-
IPSC-derived Cortical Neurons from Parkinson’s Patients with VPS35 Mutation show Defects in Synapto- and Neurogenesis
-
Is acute dystonia in a teenager psychogenic dystonia?
-
Is cathepsin D a good target for therapy in Tau-related conditions?
-
Is essential tremor-plus phenotype a prodromal phase of Parkinson’s disease ?
-
Is fatigue a rate limiting factor for achieving motor learning and functional gains in people with spinocerebellar ataxia? (PRIME-Ataxia RCT)
-
Is GPI DBS as effective to STN DBS for tremor control in Parkinson’s disease?
-
Is Neuropsychological Evaluation Needed to Assess DBS Candidacy in Essential Tremor?
-
Is the new device Percept-Medtronic really helping clinicians identifying location of contacts within the STN in STN-DBS?
-
Is the sebum RNA transcriptome analysis technique capable of non-invasively diagnosing Parkinson’s disease?
-
Istradefylline effects on L-Dopa resistant tremor in Parkinson’s disease
-
Istradefylline therapy for dystonia in Parkinson’s disease
2024 International Congress
September 27-October 1, 2024. Philadelphia, PA.